Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News
Signios Biosciences and Illumina Launch Grant for Early Access to Protein Prep 9.5K™ Platform

Signios Biosciences (“Signios Bio”), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaborat...

May 20, 2025 | Tuesday | News
Illumina Unveils DRAGEN™ v4.4 with Breakthrough Accuracy and Oncology-Ready Applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling ...

May 14, 2025 | Wednesday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News
Innovo Therapeutics Completes Phase 1 Trial of INV-101, a First-in-Class Oral Immune Metabolism Modulator

Demonstrated strong safety and favorable pharmacokinetics in Phase 1 study A First-in-class oral small molecule modulating immune cell metabolism vi...

May 13, 2025 | Tuesday | News
Biocom California and KoreaBIO Sign MOU to Strengthen US-Korea Life Science Collaboration

Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solid...

May 13, 2025 | Tuesday | News
Agilent Technologies Strengthens Presence in India and Asia with Inauguration of India Solution Center at Manesar Campus

Agilent Technologies Inc. (NYSE: A), a global leader in analytical instrumentation and laboratory solutions, today announced the official inauguration of...

May 08, 2025 | Thursday | News
GeneFab and RegCell Unite to Accelerate U.S. Clinical Manufacturing of Next-Gen Treg Therapies

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCe...

May 08, 2025 | Thursday | News
Amorepacific Unveils Skin-Regenerative Power of Vegan PDRNs Derived from Microalgae

Amorepacific revealed research findings confirming the skin-regenerative effects of polydeoxyribonucleotides (PDRNs) extracted from a microalgal source,&nb...

April 29, 2025 | Tuesday | News
Debiopharm and Oncodesign Services Partner to Advance Preclinical Radioimmunotherapy Using AbYlink™ Bioconjugation Technology

Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer an...

April 28, 2025 | Monday | News
CN Bio and Pharmaron Partner to Advance Organ-on-a-Chip Integration in Drug R&D

CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, announced the establishment o...

April 25, 2025 | Friday | News
Marc N. Casper Steers Thermo Fisher to Strong Q1 Results with $10.36 Billion Revenue and 15% EPS Growth, Defying Economic Headwinds

  First quarter revenue was $10.36 billion. First quarter GAAP diluted earnings per share (EPS) grew 15% to $3.98. First quarter adjusted EPS gre...

April 24, 2025 | Thursday | Company results
Regeneron Expands U.S. Manufacturing with $3B+ Fujifilm Partnership to Boost Biologics Capacity

Regeneron Pharmaceuticals, Inc.  announced a significant expansion of its manufacturing capacity through a new agreement with FUJIFILM Diosynth Biotec...

April 23, 2025 | Wednesday | News
UB Spin-Off POP Biotechnologies Reports 100% Protection in Preclinical Trials of H5N1 Avian Flu Vaccine

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 22, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close